< Back to Results
A Phase III Comparison of Hyperfractionated Radiation Therapy (RT) With BCNU and Conventional RT With BCNU for Supratentorial Malignant GliomaUnique Dataset IDnci-data-77ClinicalTrial.gov IDNCT03722355
This dataset will allow users to reproduce the treatment comparison between arm 1 and arm 2 in trial NCT03722355.
Clinical Trial Title
A Phase III Comparison of Hyperfractionated Radiation Therapy (RT) With BCNU and Conventional RT With BCNU for Supratentorial Malignant Glioma
Trial Summary and Conditions
Hyperfractionated radiation therapy (RT) to 72.0 Gy with BCNU will be compared to conventional radiation therapy to 60.0 Gy with BCNU to determine if hyperfractionated RT can improve the median survival time of adults with supratentorial malignant gliomas.
See data dictionary for more details.
Primary: Overall Survival [ Time Frame: From randomization to the date of death or last follow up, assessed up to 131 months. ]
Below are the clinical trial(s) associated with this dataset (all links are to ClinicalTrials.Gov):
To gain access to the data and analytic tools click here.
Data Dictionary: NCT03722355-D1-Data-Dictionary.pdf